ARCHIVES

Challoner: We Recommended FDA Replace 510(k) Clearance

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002